Gene therapy darling Oxford BioMedica pares losses – Telegraph.co.uk
Telegraph.co.uk |
Gene therapy darling Oxford BioMedica pares losses
Telegraph.co.uk A darling British biotech that is working on the development of the world's leading gene therapy for cancer has posted reduced losses and a leap in sales. Oxford BioMedica signed a deal worth up to $100m (£77m) with Swiss drugs giant Novartis last … |
